STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

T1Covered by 1 source · first reported by STAT News (health-tech) at 23 Oct, 13:00 UTC

AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.

businessscience

Sources

• T1STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billionSTAT News (health-tech)23 Oct, 13:00